{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:19:47Z","timestamp":1778879987928,"version":"3.51.4"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.blre.2021.100911","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T16:32:30Z","timestamp":1637425950000},"page":"100911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature"],"prefix":"10.1016","volume":"53","author":[{"given":"Wouter S.","family":"Hoogenboom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tharun T.","family":"Alamuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nino","family":"Balanchivadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vrushali","family":"Dabak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry B.","family":"Morrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Manwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim Q.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.blre.2021.100911_bb0005","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2021.100911_bb0010","article-title":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.blre.2021.100911_bb0015","article-title":"Covid-19: risk factors for severe disease and death","volume":"368","author":"Jordan","year":"2020","journal-title":"BMJ"},{"issue":"17","key":"10.1016\/j.blre.2021.100911_bb0020","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2020.19719","article-title":"Long-term health consequences of COVID-19","volume":"324","author":"Del Rio","year":"2020","journal-title":"JAMA"},{"issue":"7526","key":"10.1016\/j.blre.2021.100911_bb0025","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/515S2a","article-title":"Epidemiology: a moving target","volume":"515","author":"Pleasants","year":"2014","journal-title":"Nature"},{"issue":"9757","key":"10.1016\/j.blre.2021.100911_bb0030","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.blre.2021.100911_bb0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.NAJ.0000559779.40570.2c","article-title":"CE: understanding the complications of sickle cell disease","volume":"119","author":"Tanabe","year":"2019","journal-title":"Am J Nurs"},{"issue":"4 Suppl","key":"10.1016\/j.blre.2021.100911_bb0040","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"9","key":"10.1016\/j.blre.2021.100911_bb0045","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/M18-1161","article-title":"Clinical outcomes associated with sickle cell trait: a systematic review","volume":"169","author":"Naik","year":"2018","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.blre.2021.100911_bb0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjmed.2008.12.020","article-title":"Complications associated with sickle cell trait: a brief narrative review","volume":"122","author":"Tsaras","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2021.100911_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2016.08.023","article-title":"How benign is sickle cell trait?","volume":"11","author":"Gibson","year":"2016","journal-title":"EBioMedicine"},{"issue":"49","key":"10.1016\/j.blre.2021.100911_bb0060","first-page":"1155","article-title":"Incidence of sickle cell trait--United States, 2010","volume":"63","author":"Ojodu","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.blre.2021.100911_bb0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.annepidem.2020.08.005","article-title":"Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico","volume":"52","author":"Parra-Bracamonte","year":"2020","journal-title":"Ann Epidemiol"},{"issue":"3","key":"10.1016\/j.blre.2021.100911_bb0070","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jmv.26444","article-title":"Anemia is associated with severe illness in COVID-19: a retrospective cohort study","volume":"93","author":"Tao","year":"2021","journal-title":"J Med Virol"},{"issue":"14","key":"10.1016\/j.blre.2021.100911_bb0075","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/cvr\/cvaa230","article-title":"Endothelial dysfunction in COVID-19: a position paper of the ESC working group for atherosclerosis and vascular biology, and the ESC council of basic cardiovascular science","volume":"116","author":"Evans","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.blre.2021.100911_bb0080","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620962853","article-title":"COVID-19 and hypercoagulability: a review","volume":"26","author":"Kichloo","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.blre.2021.100911_bb0085","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3S","key":"10.1016\/j.blre.2021.100911_bb0090","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.annemergmed.2020.08.009","article-title":"Trends in sickle cell disease-related mortality in the United States, 1979 to 2017","volume":"76","author":"Payne","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"20","key":"10.1016\/j.blre.2021.100911_bb0095","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2019.16932","article-title":"Life expectancy and mortality rates in the United States, 1959-2017","volume":"322","author":"Woolf","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.blre.2021.100911_bb0100","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease","volume":"127","author":"Gordeuk","year":"2016","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.blre.2021.100911_bb0105","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMra0804411","article-title":"Pulmonary complications of sickle cell disease","volume":"359","author":"Gladwin","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.blre.2021.100911_bb0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2141.2011.08961.x","article-title":"Biomarkers in sickle cell disease","volume":"156","author":"Rees","year":"2012","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.blre.2021.100911_bb0115","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.blre.2021.100911_bb0120","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2021.100911_bb0125","first-page":"1","article-title":"Is sickle cell disease a risk factor for severe COVID-19 outcomes in hospitalized patients? A multicenter nationalretrospective cohort study","author":"AbdulRahman","year":"2021","journal-title":"eJHaem"},{"key":"10.1016\/j.blre.2021.100911_bb0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2021.03.044","article-title":"Impact of the coronavirus 2019 (COVID-19) on vasooclusive crisis in patients with sickle cell anaemia","volume":"106","author":"Alkindi","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.blre.2021.100911_bb0135","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1016\/S2352-3026(20)30204-0","article-title":"Prognosis of patients with sickle cell disease and COVID-19: a French experience","volume":"7","author":"Arlet","year":"2020","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.blre.2021.100911_bb0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/03630269.2020.1797775","article-title":"Impact of COVID-19 infection on 24 patients with sickle cell disease. One center urban experience, Detroit, MI, USA","volume":"44","author":"Balanchivadze","year":"2020","journal-title":"Hemoglobin"},{"issue":"13","key":"10.1016\/j.blre.2021.100911_bb0145","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/bloodadvances.2021004288","article-title":"Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease","volume":"5","author":"Mucalo","year":"2021","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.blre.2021.100911_bb0150","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3201\/eid2610.202792","article-title":"Coronavirus disease among persons with sickle cell disease, United States, march 20-may 21, 2020","volume":"26","author":"Panepinto","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.blre.2021.100911_bb0155","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jha2.87","article-title":"Low morbidity and mortality with COVID-19 in sickle cell disease: a single center experience","volume":"1","author":"Ramachandran","year":"2020","journal-title":"eJHaem"},{"issue":"11","key":"10.1016\/j.blre.2021.100911_bb0160","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.3324\/haematol.2020.259440","article-title":"Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients","volume":"105","author":"Telfer","year":"2020","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.blre.2021.100911_bb0165","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/bloodadvances.2020003741","article-title":"COVID-19 in individuals with sickle cell disease\/trait compared with other black individuals","volume":"5","author":"Singh","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.blre.2021.100911_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40001-021-00517-7","article-title":"Clinical features and prognostic factors of intensive and non-intensive 1014 COVID-19 patients: an experience cohort from Alahsa, Saudi Arabia","volume":"26","author":"Alhumaid","year":"2021","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.blre.2021.100911_bb0175","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2020.046","article-title":"Preliminary data on COVID-19 in patients with hemoglobinopathies: a multicentre ICET-A study","volume":"12","author":"de Sanctis","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"1","key":"10.1016\/j.blre.2021.100911_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/bloodadvances.2020003456","article-title":"Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection","volume":"5","author":"Minniti","year":"2021","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.blre.2021.100911_bb0185","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00277-021-04549-1","article-title":"Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals","volume":"100","author":"Boga","year":"2021","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.blre.2021.100911_bb0190","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7326\/M21-1375","article-title":"Sickle cell disorders and severe COVID-19 outcomes: a cohort study","volume":"174","author":"Clift","year":"2021","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.blre.2021.100911_bb0195","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.3324\/haematol.2021.279222","article-title":"Individuals with sickle cell disease and sickle cell trait demonstrate no increase in mortality or critical illness from COVID-19 \u2014 A fifteen hospital observational study in the Bronx, New York","volume":"106","author":"Hoogenboom","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2021.100911_bb0205","first-page":"1","article-title":"COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas","author":"Kamdar","year":"2021","journal-title":"Pediatr Hematol Oncol"},{"issue":"268","key":"10.1016\/j.blre.2021.100911_bb0210","article-title":"Sickle cell disease (SCD) and COVID-19 \u2013 a case series","volume":"9","author":"Al-Naami","year":"2021","journal-title":"J Trop Dis"},{"issue":"1","key":"10.1016\/j.blre.2021.100911_bb0215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jha2.162","article-title":"Presentation, management, and outcomes of COVID-19 in patients with sickle cell disease","volume":"2","author":"Anusim","year":"2021","journal-title":"EJHaem"},{"issue":"11","key":"10.1016\/j.blre.2021.100911_bb0220","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3324\/haematol.2020.254250","article-title":"COVID-19 in patients with sickle cell disease - a case series from a UK tertiary hospital","volume":"105","author":"Chakravorty","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2021.100911_bb0225","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.931758","article-title":"COVID-19 presentation in patients with sickle cell disease: a case series","volume":"22","author":"Chen-Goodspeed","year":"2021","journal-title":"Am J Case Rep"},{"issue":"5","key":"10.1016\/j.blre.2021.100911_bb0230","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1002\/jmv.26816","article-title":"COVID-19 in patients with sickle cell disease: a single center experience from Ohio, United States","volume":"93","author":"Sahu","year":"2021","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.blre.2021.100911_bb0235","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/s41598-020-58934-3","article-title":"Epidemiology and predictors of all-cause 30-day readmission in patients with sickle cell crisis","volume":"10","author":"Kumar","year":"2020","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.blre.2021.100911_bb0240","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.3324\/haematol.2020.255398","article-title":"COVID-19 and sickle cell disease","volume":"105","author":"Menapace","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2021.100911_bb0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fped.2020.00038","article-title":"Life-threatening infectious complications in sickle cell disease: a concise narrative review","volume":"8","author":"Ochocinski","year":"2020","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.blre.2021.100911_bb0250","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V84.2.643.643","article-title":"The acute chest syndrome in sickle cell disease: incidence and risk factors. The cooperative study of sickle cell disease","volume":"84","author":"Castro","year":"1994","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.blre.2021.100911_bb0255","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National acute chest syndrome study group","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.blre.2021.100911_bb0260","article-title":"What\u2019s the risk: differentiating risk ratios, odds ratios, and hazard ratios?","volume":"12","author":"George","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.blre.2021.100911_bb0265","article-title":"Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study","volume":"374","author":"Hippisley-Cox","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.blre.2021.100911_bb0270","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1111\/bjh.16779","article-title":"COVID-19 infection and sickle cell disease: a UK centre experience","volume":"190","author":"McCloskey","year":"2020","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.blre.2021.100911_bb0280","doi-asserted-by":"crossref","first-page":"E154","DOI":"10.1002\/ajh.25809","article-title":"COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient","volume":"95","author":"Beerkens","year":"2020","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.blre.2021.100911_bb0285","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/bjh.16734","article-title":"COVID-19 infection in patients with sickle cell disease","volume":"189","author":"Hussain","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.blre.2021.100911_bb0290","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.htct.2020.11.005","article-title":"Acute chest syndrome and COVID-19 in sickle cell disease pediatric patients","volume":"43","author":"Elia","year":"2021","journal-title":"Hematol Transfus Cell Ther"},{"issue":"12","key":"10.1016\/j.blre.2021.100911_bb0295","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.3324\/haematol.2019.238295","article-title":"The proteome of neutrophils in sickle cell disease reveals an unexpected activation of interferon alpha signaling pathway","volume":"105","author":"Hermand","year":"2020","journal-title":"Haematologica"},{"issue":"10238","key":"10.1016\/j.blre.2021.100911_bb0300","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2021.100911_bb0305","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3389\/fimmu.2020.01061","article-title":"Interferon-\u03b12b treatment for COVID-19","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Immunol"},{"issue":"18","key":"10.1016\/j.blre.2021.100911_bb0310","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.blre.2021.100911_bb0315","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1097\/INF.0000000000003043","article-title":"Risk factors for severe COVID-19 in children","volume":"40","author":"Graff","year":"2021","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.blre.2021.100911_bb0320","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s11239-021-02398-3","article-title":"Stroke and presence of patent foramen ovale in sickle cell disease","volume":"52","author":"Aggeli","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"10.1016\/j.blre.2021.100911_bb0325","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.blre.2021.100911_bb0330","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijid.2021.01.036","article-title":"Epidemiology, characteristics and outcome of children hospitalized with COVID-19 in Oman: a multicenter cohort study","volume":"104","author":"Al Yazidi","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.blre.2021.100911_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28420","article-title":"COVID-19 disease in new York City pediatric hematology and oncology patients","volume":"67","author":"Gampel","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.blre.2021.100911_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092950","article-title":"The wide Spectrum of COVID-19 clinical presentation in children","volume":"9","author":"Nathan","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.blre.2021.100911_bb0345","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jca.21809","article-title":"Red blood cell exchange to avoid intubating a COVID-19 positive patient with sickle cell disease?","volume":"35","author":"Allison","year":"2020","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1016\/j.blre.2021.100911_bb0350","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ccr3.3526","article-title":"The role of red blood cell exchange in sickle cell disease in patient with COVID-19 infection and pulmonary infiltrates","volume":"9","author":"Okar","year":"2020","journal-title":"Clin Case Rep"},{"issue":"4","key":"10.1016\/j.blre.2021.100911_bb0355","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/ccr3.3960","article-title":"Severe hemolysis and vaso-occlusive crisis due to COVID-19 infection in a sickle cell disease patient improved after red blood cell exchange","volume":"9","author":"Okar","year":"2021","journal-title":"Clin Case Rep"},{"issue":"10","key":"10.1016\/j.blre.2021.100911_bb0360","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3324\/haematol.2021.278573","article-title":"Low incidence of COVID-19 severe complications in a large cohort of children with sickle cell disease: a protective role for basal interferon-1 activation?","volume":"106","author":"Brousse","year":"2021","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.blre.2021.100911_bb0365","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2009-05-221333","article-title":"The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)","volume":"115","author":"Voskaridou","year":"2010","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.blre.2021.100911_bb0370","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","article-title":"How I use hydroxyurea to treat young patients with sickle cell anemia","volume":"115","author":"Ware","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.blre.2021.100911_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28579","article-title":"Acute chest syndrome in the setting of SARS-COV-2 infections-a case series at an urban medical center in the Bronx","volume":"67","author":"Morrone","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"14","key":"10.1016\/j.blre.2021.100911_bb0380","doi-asserted-by":"crossref","first-page":"422","DOI":"10.15585\/mmwr.mm6914e4","article-title":"Coronavirus disease 2019 in children - United States, February 12-April 2, 2020","volume":"69","author":"Team","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.blre.2021.100911_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28547","article-title":"A Saudi family with sickle cell disease presented with acute crises and COVID-19 infection","volume":"67","author":"Al-Hebshi","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.blre.2021.100911_bb0390","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1097\/MPH.0000000000002061","article-title":"Coronavirus disease 2019 (COVID-19) infection in children with sickle cell disease: case series from Oman","volume":"43","author":"Al Sabahi","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"10.1016\/j.blre.2021.100911_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28392","article-title":"COVID-19 in pediatric oncology from French pediatric oncology and hematology centers: high risk of severe forms?","volume":"67","author":"Andre","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.blre.2021.100911_bb0400","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1111\/bjh.17013","article-title":"Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases","volume":"190","author":"Appiah-Kubi","year":"2020","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.blre.2021.100911_bb0405","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28430","article-title":"SARS-CoV-2 infection in pediatric patient with hemoglobin SC disease","volume":"67","author":"Dagalakis","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2021.100911_bb0415","article-title":"Multisystem inflammatory syndrome in a pediatric patient with sickle cell disease and COVID-19: a case report","author":"Espanol","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.blre.2021.100911_bb0420","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1111\/bjh.16802","article-title":"Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit","volume":"190","author":"Heilbronner","year":"2020","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.blre.2021.100911_bb0425","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28511","article-title":"A pediatric patient with sickle cell disease presenting with severe anemia and splenic sequestration in the setting of COVID-19","volume":"67","author":"Jacob","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.blre.2021.100911_bb0430","article-title":"COVID-19 infection and acute pulmonary embolism in an adolescent female with sickle cell disease","volume":"12","author":"Kasinathan","year":"2020","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.blre.2021.100911_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28874","article-title":"Acute hepatic encephalopathy and multiorgan failure in sickle cell disease and COVID-19","volume":"68","author":"Martone","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.blre.2021.100911_bb0440","doi-asserted-by":"crossref","first-page":"E192","DOI":"10.1002\/ajh.25855","article-title":"Dramatic improvement after tocilizumab of severe COVID-19 in a child with sickle cell disease and acute chest syndrome","volume":"95","author":"Odievre","year":"2020","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.blre.2021.100911_bb0445","first-page":"120","article-title":"Simultaneous diagnosis of severe SARS-CoV-2 infection and sickle cell disease in two infants","volume":"19","author":"Parodi","year":"2021","journal-title":"Blood Transfus"},{"key":"10.1016\/j.blre.2021.100911_bb0450","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jha2.53","article-title":"Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS-CoV-2 positivity","volume":"1","author":"Quaresima","year":"2020","journal-title":"EJHaem"},{"issue":"3","key":"10.1016\/j.blre.2021.100911_bb0455","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28707","article-title":"Cranial polyneuropathy as the first manifestation of a severe COVID-19 in a child","volume":"68","author":"Roussel","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.blre.2021.100911_bb0460","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/ccr3.3774","article-title":"COVID-19 pneumonia in a pediatric sickle cell patient requiring red blood cell exchange","volume":"9","author":"Walker","year":"2021","journal-title":"Clin Case Rep"},{"issue":"1","key":"10.1016\/j.blre.2021.100911_bb0465","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13613-020-00790-5","article-title":"Characteristics and risk factors associated with critical illness in pediatric COVID-19","volume":"10","author":"Fisler","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"12","key":"10.1016\/j.blre.2021.100911_bb0470","doi-asserted-by":"crossref","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","article-title":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020","volume":"69","author":"Team","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.blre.2021.100911_bb0475","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4269\/ajtmh.20-1657","article-title":"Association of sickle cell trait with risk and mortality of COVID-19: results from the United Kingdom biobank","volume":"105","author":"Resurreccion","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"18","key":"10.1016\/j.blre.2021.100911_bb0480","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1182\/bloodadvances.2021004977","article-title":"Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection","volume":"5","author":"Merz","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2021.100911_bb0485","first-page":"1","article-title":"Outcomes of COVID-19 in pregnant women with sickle cell disease in India: a case series","author":"Waghmare","year":"2021","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"10.1016\/j.blre.2021.100911_bb0490","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1111\/bjh.17089","article-title":"Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection","volume":"191","author":"Sheha","year":"2020","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.blre.2021.100911_bb0495","article-title":"COVID-19 in patients with hematologic-oncologic risk factors: complications in three patients","volume":"12","author":"Tafti","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.blre.2021.100911_bb0500","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cca.2020.06.013","article-title":"C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection","volume":"509","author":"Sahu","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.blre.2021.100911_bb0505","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/jmv.26346","article-title":"COVID-19 and coagulation dysfunction in adults: a systematic review and meta-analysis","volume":"93","author":"Lin","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.blre.2021.100911_bb0510","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1756-0500-7-264","article-title":"The clinical case report: a review of its merits and limitations","volume":"7","author":"Nissen","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.blre.2021.100911_bb0515","article-title":"Incidence of SARS-COV-2 infection in sickle cell patients presenting with a painful crisis: a 12-month prospective cohort study","author":"Kont\u00e9","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"10.1016\/j.blre.2021.100911_bb0520","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.arcped.2020.05.010","article-title":"Severe and fatal forms of COVID-19 in children","volume":"27","author":"Oualha","year":"2020","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.blre.2021.100911_bb0525","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijid.2020.09.1433","article-title":"COVID-19 and sickle cell disease in Bahrain","volume":"101","author":"AbdulRahman","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.blre.2021.100911_bb0530","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.4103\/jfmpc.jfmpc_2210_20","article-title":"SARS CoV-2 infection in a patient with sickle cell disease - atypical presentation","volume":"10","author":"Al-Naami","year":"2021","journal-title":"J Family Med Prim Care"},{"issue":"1","key":"10.1016\/j.blre.2021.100911_bb0535","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2020.074","article-title":"COVID-19 in Omani children with hemato-oncology diseases","volume":"12","author":"Al Yazidi","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"7","key":"10.1016\/j.blre.2021.100911_bb0540","first-page":"345","article-title":"SARS-CoV-2 infection in patients with sickle cell disease","volume":"157","author":"Arguello-Marina","year":"2021","journal-title":"Med Clin (Engl Ed)"},{"key":"10.1016\/j.blre.2021.100911_bb0545","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.74","article-title":"Sickle cell disease and COVID-19: atypical presentations and favorable outcomes","author":"Azerad","year":"2020","journal-title":"EJHaem"},{"issue":"7","key":"10.1016\/j.blre.2021.100911_bb0550","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ajh.25833","article-title":"Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab","volume":"95","author":"De Luna","year":"2020","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.blre.2021.100911_bb0555","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1111\/trf.16068","article-title":"Sickle cell anemia and COVID-19: use of voxelotor to avoid transfusion","volume":"60","author":"Ershler","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2021.100911_bb0560","article-title":"Acute lung failure due to COVID-19 in a patient with sickle cell anemia","volume":"59","author":"Fronza","year":"2020","journal-title":"Minerva"},{"issue":"2","key":"10.1016\/j.blre.2021.100911_bb0565","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/ccr3.3719","article-title":"Clinical presentations and outcomes of COVID-19 infection in sickle cell disease patients: case series from Komfo Anokye teaching hospital, Ghana","volume":"9","author":"Hardy","year":"2021","journal-title":"Clin Case Rep"},{"issue":"3","key":"10.1016\/j.blre.2021.100911_bb0570","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.htct.2020.06.003","article-title":"COVID-19 as a trigger of acute chest syndrome in a pregnant woman with sickle cell anemia","volume":"42","author":"Justino","year":"2020","journal-title":"Hematol Transfus Cell Ther"},{"issue":"6","key":"10.1016\/j.blre.2021.100911_bb0575","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ajh.25821","article-title":"Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)","volume":"95","author":"Nur","year":"2020","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.blre.2021.100911_bb0580","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.4655","article-title":"A fresh breath of oxygen: red blood cell exchange transfusion in sickle cell and COVID-19","volume":"9","author":"Nguyen","year":"2021","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.blre.2021.100911_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebr.2021.100436","article-title":"Rapid development of seizures and PRES in a Covid-19 patient","author":"Santos de Lima","year":"2021","journal-title":"Epilepsy Behav Rep"},{"issue":"1","key":"10.1016\/j.blre.2021.100911_bb0590","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12890-021-01412-x","article-title":"Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report","volume":"21","author":"Teulier","year":"2021","journal-title":"BMC Pulm Med"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2100117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2100117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:27:59Z","timestamp":1759436879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X2100117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":115,"alternative-id":["S0268960X2100117X"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2021.100911","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2021.100911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100911"}}